ArticleAmerican journal of translational research2024

Efficacy and safety analysis of PD-1 combined with regorafenib in the treatment of advanced hepatocellular carcinoma.

Lu Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.